News

January 03, 2018

Presenting at the Biotech Showcase™ Annual Conference 2018. 

 

Pin Therapeutics, Inc. to present at the Biotech Showcase™ Annual Conference on January 10 2018.

 

Hyunsun Jo, CEO, will present at the Biotech Showcase™ as follows:

 

Date: Wed, January 10, 2018 

Time: 11:15 AM (PST) 

Room: Franciscan - A (Ballroom Level) 

Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA (United States) 

 

Pin aims to create therapeutic products based on chemical biology driven protein degradation including the PROTAC technology, which utilizes bifunctional compounds to degrade target proteins within the cell. The PROTAC compounds can hijack the ubiquitin and/or ubiquitin-like molecule E3 ligase system to degrade target proteins. Pin is building in-house capability and a network of collaborator to develop PROTAC compounds for oncology, neurodegenerative diseases, and membrane protein indications in the beginning, but basically disease-agnostic. 

 

Pin’s uniqueness is largely coming from two aspects: 

1. Biological specificity for target’s degradation hijacking and recruiting unique ubiquitin and/or ubiquitin-like biology

2. Unique technologies that PROTAC compounds can be efficiently developed and a variety of screening assays

 

Pin Therapeutics, Inc.

www.pintherapeutics.com

Please reload